|
Acusphere, Inc. - Company Profile Snapshot
| Company Profile: |
Acusphere, Inc. |
| Ticker: |
ACUS |
| Exchanges: |
OTC |
| 2008 Sales: |
2,684,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Service Organizations |
| Country: |
UNITED STATES |
| Employees: |
118 |
Business Description
Acusphere, Inc.. The Group's principal activity is to develop new drugs and improved formulations of existing drugs using proprietary porous microparticle technology. It focused on developing proprietary drugs, including improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost. It develops proprietary drug that offers benefits such as improved safety and efficacy, increased patient compliance and greater ease of use. Its products are in clinical development and are designed to address clinical needs within cardiology, oncology and asthma. It has initially applied its technology in its research and development efforts in areas of AI-700, Intravenous Delivery of Gas for Ultrasound Contrast; AI-850, first clinical-stage product candidate from its Hydrophobic Drug Delivery System, and AI-128, first clinical-stage product candidate from its Pulmonary Drug Delivery System. The Group is a development stage company.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
